Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
TTX Company $350 Million Medium-Term Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by TTX…
TTX Company $350 Million Medium-Term Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by TTX…
Symantec Acquires Blue Coat
Davis Polk is advising JP Morgan as lead financial adviser to Symantec Corporation in connection with its $4.65 billion…
Under Armour, Inc. $600 Million Senior Notes Offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by Under…
The Medicines Company $402.5 Million Convertible Senior Notes Offering
Davis Polk advised the joint bookrunners in connection with a Rule 144A offering by The Medicines Company of $402.5 million…
Davis Polk Advises Baker Hughes Incorporated on Its Cash Tender Offer
Davis Polk advised Baker Hughes Incorporated in connection with its waterfall cash tender offer for $1 billion aggregate…
Davis Polk Advises Baker Hughes Incorporated on Its Cash Tender Offer
Davis Polk advised Baker Hughes Incorporated in connection with its waterfall cash tender offer for $1 billion aggregate…
CVR Partners, LP and CVR Nitrogen Finance Corporation $645 Million Senior Secured Notes Offering and Concurrent Tender Offer and Consent Solicitation
Davis Polk advised the representative of the initial purchasers on a Rule 144A/Regulation S offering by CVR Partners, LP and…
The Medicines Company $402.5 Million Convertible Senior Notes Offering
Davis Polk advised the joint bookrunners in connection with a Rule 144A offering by The Medicines Company of $402.5 million…
The Medicines Company $402.5 Million Convertible Senior Notes Offering
Davis Polk advised the joint bookrunners in connection with a Rule 144A offering by The Medicines Company of $402.5 million…